The Boston Scientific spinal cord stimulator cases are now federal products-liability proceedings in MDL No. 3181 before Judge Josephine L. Staton in the Central District of California.
The outcome will likely turn on expert proof linking specific design changes, warnings, and device performance to each patient's injury. A spinal cord stimulator is an implanted system that sends electrical pulses to spinal nerves to reduce chronic pain. These proceedings involve implanted chronic-pain patients who needed revision or removal surgery after alleged defects and warning failures.
Table of Contents
- What the MDL will test
- Which device history experts will dissect
- What injury reports show — and what they do not prove
- What implanted patients can document now
What the MDL will test
The Judicial Panel on Multidistrict Litigation created MDL No. 3181 on June 5, 2026, according to the transfer order. Centralization places related federal cases before one judge for shared discovery and early rulings. That structure speeds decisions on documents, witnesses, and experts. The shared questions concern regulatory compliance, device performance, warnings, and injuries linked to Boston Scientific stimulators.
Plaintiffs allege design and manufacturing defects, inadequate testing, and warning failures. They also challenge use of PMA supplements to avoid full new approval. Experts will therefore face three linked questions. Did the design perform safely in the body. Did manufacturing and testing catch foreseeable failures. Did warnings give doctors and patients usable risk information.
Which device history experts will dissect
Boston Scientific's Precision spinal cord stimulation system originated under FDA premarket approval P030017, approved April 27, 2004, as shown in the FDA approval record. Later changes were handled through PMA supplements. That supplement path is now a central dispute. Plaintiffs allege the company used supplements to avoid full new approval while design risks remained.
Defense experts will likely describe supplements as a lawful route for incremental change. Plaintiffs' experts will likely trace each supplement to testing, risk review, and labeling updates. A concrete performance example comes from the WaveWriter Alpha 16 and 32 IPG kits. FDA classified a July 17, 2024 recall of about 77,674 kits as Class II because the generator could reset while charging and briefly interrupt stimulation. Experts can use that event to test how resets, charging behavior, and stimulation loss were evaluated and warned about.
What injury reports show — and what they do not prove
In a September 2020 clinician letter, FDA said it reviewed 107,728 spinal cord stimulator reports from 2016-2020, including 30,321 unsatisfactory-pain-relief reports and hundreds of deaths. FDA urged trial stimulation before permanent implant. A 2018 Associated Press investigation found more than 80,000 stimulator injury incidents reported to FDA since 2008, involving shocks, burns, and nerve damage up to paraplegia. Those numbers help explain why courts take device performance and patient selection seriously.
Unsatisfactory pain relief points toward effectiveness questions. Shocks, burns, nerve injury, reset-related interruption, and repeat surgery point toward safety and tolerability questions. Adverse-event reports alone do not decide defect or causation. TorHoerman Law's explanation of FDA data limits states that reports only signal possible risks and do not by themselves prove defect or cause, so experts must causally link the device, supplement change, and warning to harm. That link requires device records, operative findings, imaging, timelines, and rule-out of other causes.
What implanted patients can document now
Revision or removal cases depend on paper proof. Operative reports show why a lead or generator was repositioned, replaced, or explanted. Device identification records tie the harm to a model, lot, and implant date.
Pain scores, programming visits, charging problems, and emergency visits show frequency and severity. A reader considering legal review should seek prompt medical care for new weakness, bowel or bladder change, fever, spreading redness, severe pain, or repeated shocks. Preserve explanted hardware instructions from the surgeon rather than discarding or returning it informally.
- Keep the implant card, hospital discharge papers, and device model information
- Save operative reports for implant, revision, and removal procedures
- List dates of loss of relief, shocks, burns, infection, reset, or charging trouble
- Keep imaging, wound photos where clinically appropriate, bills, and missed-work records
- Bring a timeline and medication or injections tried before and after implant
You Might Also Like
- Boston Scientific Spinal Cord Stimulator Products-Liability Proceedings: What the Court Filings Say—and What They Do Not Establish
- Boston Scientific Spinal Cord Stimulator Products-Liability Proceedings: Undisputed Facts vs. Contested Allegations
- Dupixent Products-Liability MDL 3180: Evidence and Expert Questions That Could Shape the Outcome